2025-07-15 - Analysis Report
Okay, here's a report analyzing Hims & Hers Health Inc (HIMS), incorporating all the provided data points.

## Hims & Hers Health Inc (HIMS) Stock Analysis

**Company Overview:** Hims & Hers Health Inc is a telehealth company that offers personalized health and wellness solutions direct to consumers.

**1. Performance Relative to S&P 500 (VOO):**

*   **HIMS Cumulative Return:** 187.73%
*   **VOO Cumulative Return:** 64.44%
*   **Absolute Divergence (Current):** 120.7
*   **Relative Divergence (Current):** 55.4 (This indicates the current divergence is in the upper-middle range of its historical divergence, suggesting HIMS is significantly outperforming VOO but not at its peak outperformance.)

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD   | Alpha  | Beta  | Cap(B) |
|------------|---------|-------|--------|-------|--------|
| 2019-2021  | -46.0%  | 51.0% | -84.0% | -0.0 | 1.5    |
| 2020-2022  | -15.0%  | 72.1% | -17.0% | -0.0 | 1.4    |
| 2021-2023  | -51.0%  | 72.1% | -69.0% | -0.1 | 2.0    |
| 2022-2024  | 127.0%  | 78.4% | 101.0% | -0.1 | 5.4    |
| 2023-2025  | 183.0%  | 78.4% | 135.0% | -0.1 | 11.7   |

*   **Analysis:** The table reveals a highly volatile performance history.
    *   **CAGR:**  CAGR values are volatile over different period, indicating a high-growth but unstable stock. Recent years show strong positive growth.
    *   **MDD:**  High Maximum Drawdown (MDD) figures indicate significant risk.
    *   **Alpha:** Negative alpha values in the earlier periods suggest underperformance relative to the benchmark (S&P 500) on a risk-adjusted basis. The latest periods show very high positive alpha, meaning HIMS is generating substantial excess returns.
    *   **Beta:** Beta values close to zero suggest a very low correlation with the S&P 500, meaning HIMS moves independently of the market.
    *   **Cap:** Market capitalization has been increasing, reflecting growth in the company's size.

**2. Recent Stock Price Movement:**

*   **Current Price:** 52.03
*   **Previous Close:** 47.89
*   **Change:** 8.64
*   **5-day Moving Average:** 50.43
*   **20-day Moving Average:** 50.78
*   **60-day Moving Average:** 48.91

*   **Analysis:** The current price is above all three moving averages, indicating a short-term and medium-term upward trend. The significant positive change from the previous close (8.64) indicates a strong bullish movement in the most recent trading session.

**3. Technical Indicators and Expected Return:**

*   **Market Risk Indicator (MRI):** 0.3372 (Low Risk)
*   **RSI:** 70.42 (Overbought)
*   **PPO:** 0.2412
*   **Hybrid Signal:** cash_14%_Buy 80% of cash (2165 shares - Caution - MRI:0.34)
*   **20-day Relative Divergence Change:** +0.9 (Indicates Short-Term Upward Momentum)
*   **Expected Return:** -16.2% (Long-term, relative to S&P 500)

*   **Analysis:**
    *   The MRI indicates low risk.
    *   The RSI suggests the stock is currently overbought, which could signal a potential pullback.
    *   The Hybrid Signal recommends buying with caution, noting the MRI.
    *   The positive change in relative divergence confirms recent upward momentum.
    *   The negative expected return suggests that, from the current price level, long-term returns are expected to underperform the S&P 500.

**4. Recent News & Significant Events:**

*   **2025-07-15:** HIMS experiencing major business developments, regulatory changes, or market events.
*   **2025-07-12:** Analysts discussing HIMS's performance and outlook.
*   **2025-07-13:** Notable stock volatility due to recent news, earnings reports, or executive actions.
*   **2025-07-14:** Market experts highlight both risks and opportunities, advising monitoring of news and announcements.

*   **Analysis:** The recent news highlights volatility and significant changes around HIMS, suggesting investors should stay informed about further developments.

**5. Recent Earnings Analysis:**

| 날짜       | EPS   | 매출    |
|------------|-------|---------|
| 2025-05-05 | 0.22  | 0.59 B$ |
| 2024-11-04 | 0.35  | 0.40 B$ |
| 2024-08-05 | 0.06  | 0.32 B$ |
| 2024-05-06 | 0.05  | 0.28 B$ |
| 2025-05-05 | 0.05  | 0.28 B$ |

*   **Analysis:**
    *   EPS shows variability, indicating inconsistent profitability.
    *   Revenue shows a clear upward trend, indicating growth in sales.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-03-31   | $0.59B     | 73.50%        |
| 2024-12-31   | $0.48B     | 76.81%        |
| 2024-09-30   | $0.40B     | 79.16%        |
| 2024-06-30   | $0.32B     | 81.30%        |
| 2024-03-31   | $0.28B     | 82.36%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE       |
|--------------|------------|-----------|
| 2025-03-31   | $0.55B     | 9.01%     |
| 2024-12-31   | $0.48B     | 5.46%     |
| 2024-09-30   | $0.44B     | 17.18%    |
| 2024-06-30   | $0.36B     | 3.67%     |
| 2024-03-31   | $0.34B     | 3.23%     |

*   **Analysis:**
    *   **Revenue:** Exhibits a consistent upward trend, reflecting growth in the company's sales.
    *   **Profit Margin:** Shows a downward trend, which could be a concern if this indicates decreasing efficiency in converting revenue to profit.
    *   **Equity:** Increasing equity suggests the company's net worth is growing.
    *   **ROE:** Return on Equity is volatile, reflecting fluctuations in profitability relative to equity.

**7. Overall Analysis & Conclusion:**

Hims & Hers Health Inc (HIMS) presents a mixed investment picture.

*   **Strengths:** The company exhibits strong revenue growth, has significantly outperformed the S&P 500 historically, and operates in a sector (telehealth) with potential for future expansion. The Market Risk Indicator suggests a low-risk environment.
*   **Weaknesses:** High historical volatility, a recent overbought RSI, decreasing profit margins, and a negative long-term expected return are concerning.  The inconsistent EPS and volatile ROE further highlight profitability concerns. The low beta and high alpha imply unique stock-specific factors are driving the stock rather than overall market trends.
*   **Considerations:** The recent news suggests the company is undergoing significant changes, which could lead to both risks and opportunities. Investors should closely monitor upcoming earnings reports, company announcements, and industry developments.

**Recommendation:** Given the overbought conditions and negative long-term outlook despite the recent surge, a **cautious approach** is warranted. Current investors might consider taking some profits, while potential investors should wait for a pullback and further clarity on the company's future direction before initiating a position. Continuous monitoring of news and financial performance is crucial.
